Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing '1'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Heinreich J Verfahren zur Darstellung vonBeta-(3,4,5-Trialkoxyphenyl)-aethylaminen... German Patentschrift 1931
Ardis AE, Baltzly R, Scho... Amines Related to 2,5-Dimethoxyphenethylamine. 111 2-Hydroxy and 2-Met... Journal of American ... 1946
Rinkel M Discussion at Annual Meeting of the American Psychiatric Association i... J. Clin. Exper. Psyc... 1951
Arnold OH, Hoff H Untersuchungen über die Wirkungsweise von Lysergsäurediäthylamide (1. ... Wien. Ztschr. Nerven... 1953
Stoll A, Rutschmann J, Ho... Ueber die Synthese von C14-diäthylamin und C14-lysergsäure-diäthylamid Helv. chim. Acta 1954
Graham JDP, Khalidi AI The actions of d-lysergic acid diethylamide (L.S.D. 25). Part 1. Gene... J. Fac. Med. Iraq. 1954
Fabing HD Experimental compound MER-17 (Frenquel): A new blocking agent against ... Psychiatr. Res. Rep. 1955
Stoll A, Rothlin E, Rutsc... Distribution and fate of 14C-labeled lysergic acid diethylamide (LSD 2... Experientia 1955
Lienert GA Pharmakopsychologische Untersuchungen über den Abbau der geistigen Lei... Verlag fur Psycholog... 1956
Oinzel K H, Mayer-Gross W Prevention of Psychological Effects of D-Lysergic Acid Deithylamide (L... Nature 1956
Ginzel KH, Mayer-Gross W Prevention of psychological effects of d-lysergic acid diethylamide (L... Nature 1956
Jarvik ME Mechanism of action of lysergic acid diethylamide, serotonin, and rela... American Association... 1956
Cerletti A Lysergic acid diethylamide (LSD) and related compounds. (Psychopharma... Josiah Macy Jr. Foun... 1956
Kar AB, Boscott RJ Preliminary investigations on the influence of reserpine and lysergic ... Indian J. Pharmacy 1956
Abramson HA Blocking of the LSD-25 reaction in Siamese fighting fish.(Neuropharmac... Josiah Macy Foundati... 1957
Jarvik ME Effect of LSD-25 on snails. (Neuropharmacology. Transacitons of the ... Josiah Macy Foundati... 1957
Elkes J Effects of psychotomimetic drugs in animals and man. (Neuropharmacolo... Josiah Macy Foundati... 1957
Brodie BB Serotonin and norepinephrine as antagonistic chemical mediators regula... Josiah Macy Foundati... 1957
Clark LD, Bliss EL Psychopharmacological studies of lysergic acid diethylamide (LSD 25) i... Arch. Neurol. Psychi... 1957
Ginzel KH The action of lysergic acid diethylamide (LSD 25), its 2-brom derivati... J. Physiol. 1957
Salmoiraghi GC, Page IH Effects of LSD 25, BOL 148, bufotenine, mescaline and ibogaine on the ... J. Pharmacol. Exper.... 1957
Purpura DP Origin of cortical surface potentials (Nueropharmaocology. Transaction... Josiah Macy Foundati... 1957
Abramson HA, Sklarofsky A... Lysergic acid diethylamide (LSD-25) antagonists. II. Development of ... Arch. Neurol. & Psyc... 1958
Pierre R, Cahn J, Herold ... Actions de la 21 hydroxypregnanedione et du méthyl-androstanolone sur ... Thérapie 1958
Jatzkewitz H Psychotropie Substanzen und "endogene" Psychose. (Pathophysiologische... Confinia neurol. 1958
Solms H Die Bedeutung "vergleichend-pharmakopsychiatrischer Analyse" für das S... Confina neurol. 1958
Lienert GA Ueber eigenartige Motivationsvorg�nge unter Wirkung von Lysergsäure-... Verlag für Psycho... 1958
Leuner Ueber Modellpsychosen. (8. Lindauer Psychotherapiewoche, Mai 1958) Wien.med.Wschr. 1958
Ostfeld AM, Visotsky HM, ... A comparison of the psychotomimetic effects of scopolamine, lysergic a... Clin. Res. 1958
Arnold OH, Hofmann G, Leu... Untersuchungen zum Schizophrenieproblem. IV.Mitteilung: Die Verteilu... Wien.Ztschr.Nervenhk... 1958
Keup W LSD-25 und der Eiweiss-Stoffwechsel der Rattenhirnrinde während der En... Confinia neurol. 1958
Cahn J, Herold M, Dubrasq... Contribution a un concept biochimique des psychoses experimentales. VI... C.R.Soc.Biol. 1958
Balestrieri A, Fontanari ... Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148 Arch.Gen.Psychiat. 1959
Orsini F, Benda P Etude expérimentale du ralentissement de la performance sous LSD-25. ... Ann.med.-psychol. 1959
Isbell H, Miner EJ, Logan... Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) ... Psychopharmacologia 1959
Orsini F, Benda P Etude expérimentale du ralentissement de la performance sous LSD-25. (... Presse med. 1959
Benda P, Orsini F A propos de l'étrangeté temporo-spatiale sous LSD-25. (Soc.méd.-psych... Ann.med.-psychol. 1959
Benda P, Orsini F A propos de l'étrangete temporo-spatiale sous LSD 25. (Soc.méd.-psych... Presse méd. 1959
Balestieri A, Fontanari D Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148 Neuro-Psychopharmaco... 1959
Scott KG, Stone RS The anti-tumor action of lysergic acid derivatives and their serotonin... Cancer Res. 1959
Greig ME, Gibbons AJ Effect of various psychotomimetic drugs on rate of appearance of carbo... Amer. J. Physiol. 1959
Sandoz Laboratories Basle Methysergide (UML-491), a new serotonin antagonist Scientific Exhibit, ... 1960
Balestrieri A Studies on cross tolerance with LSD-25, UML-491 and JB-336 Psychopharmacologia 1960
Lebovits BZ, Visotsky HM,... LSD and JB-318: A comparison of two hallucinogens. I. An explorator... A.M.A. Arch. gen. Ps... 1960
Lebovits BZ, Visotsky HM,... Lysergic acid diethylamide (LSD) and JB-318: A comparison of two hall... A.M.A.Arch.Gen.Psych... 1960
Robinson JT Discussion (LSD and psychotherapy. Roy. Soc. Med., Sect. Psychiat., Lo... Proc. Roy. Soc. Med. 1960
Hofmann A, Tscherter H Isolierung von Lysergsaure-Alkaloiden aus der mexikanischen Zauberdrog... Sept. Exp. 1960
A Balestrieri Studies on cross tolerance with LSD-25, UML-491 and JB-336. Psychopharmacologia 1960
Hill CR Lead-210 and polonium-210 in grass Nature 1960
Kays JM, Garrett R The Effect of Three Dose Levels of EA1729 (LSD) Upon Tracking Proficie... Military Report 1961
Barolin GS Erstes Europäisches Symposium für Psychotharapie unter LSD-25, Götting... Wien.med. Wschr. 1961
Pascal E, Gamna G Modificazioni di comportamento delle processionarie del pino per effet... Ann. freniatr. 1961
RW Buck Notes and Brief Articles - Mushroom Poisoning since 1924 in the United... Mycologia 1961
Ostfeld AM Effects of LSD 25 and JB 318 on tests of visual and perceptual functio... Fed. Proc. 1961
Colville KI, Lindsay LA B.W. 57-301, a pyrimidine derivative with potent and specific antisero... Fed. Proc. 1962
Lebovits BZ, Visotsky HM,... LSD and JB 318: A comparison of two hallucinogens. III. Qualitative an... Arch. gen. Psychiat. 1962
Bender L, Goldschmidt L, ... Treatment of Autistic Schizophrenic Children with LSD-25 and UML-491 Recent Advances in B... 1962
DELAHUNT CS, O'CONNOR RA,... Toxic retinopathy following prolonged treatment with dl-p-trifluoromet... Toxicol Appl Pharmac... 1963
Sackler AM, Weltman AS, O... Effects of lysergic acid diethylamide on urinary 17-ketosteroid and 17... Nature 1963
TR Shanthaveerappe, K Nan... Histochemical Studies on the Mechanism of Action of the Hallucinogens ... Acta Neuropath. 1963
Shanthaveerappa T R, Nand... Histochemical Studies on the Mechanism of Action of the Hallucinogens ... Acta Neuropath. (Ber... 1963
Kandié B, Dordevic D Komparacija psihofarmaka LSD-25, BOL-148 i psilocibina u klinickoj pra... Vojnosanit. Pregl. 1963
Kandic B, Djordjevic D Komparation von psychopharmaka LSD-25, BOL-148 und psilocybin in Klini... Vojnosanit. Pregl. 1963
SH Snyder, RJ Wartman, J ... The Physiological Disposition of C14-Serotonin in the Rat Uterus J. Pharmacol. & Exp.... 1964
PA Stadler, F Troxler, AJ... Selektive Reduktions- und oxydationsreaktionen an Lysergsaure-Derivate... Helv. Chim. Acta 1964
Massoni RS Tratamiento de jovenes ezquizofrenicos con LSD 25 y UML 491 Med. práct. 1964
K Nandy, TR Shanthaveerap... The effect of d-lysergic acid diethylamide tartrate (LSD-25) and d-2-b... Acta histochem. (Je... 1964
Ketchum JS, Aghajanian GK... THE HUMAN ASSESSMENT OF EA 1729 [LSD] AND EA 3528 BY THE INHALATION RO... CHEMICAL RESEARCH AN... 1964
Hill CR Polonium-210 in man Nature 1965
Little JB, Radford EP, Mc... Distribution of polonium-210 in pulmonary tissues of cigarette smokers N Engl J Med 1965
Thuillier J, Nakajima H Analogies et différences neuropharmacologiques entre les hallucinogène... Arzneimittelforschun... 1966
GR Wood The Physician and the 1965 Drug Abuse Control Amendments GP 1966
J Thuillier & H Nakajima Analogies et differences neuropharmacologiques entre les hallucinogene... Arzneimittelforschun... 1966
Editorial Drug Control Law Poses Increased Paper Work: MDs must keep full recor... Med. World News 1966
Editorial Drug Control Law Poses Increased Paper Work; MD's must keep full reco... Med. World News 1966
Neuhoff V Die Wirkung von Lysergsäurediätheylamid auf Gangliezellen. 1. Mitteilu... Arzneimittel-Forsch 1967
Van den Driessche J, Alla... Antagonisme de la 1 [2-(5, 6 diméthyl-3 indolyl) éthyl-4 phényl-pipéra... C.R. Soc. Biol. 1968
Bennet G LSD: 1967 Brit. J. Psychiat. 1968
Vojtechovsky M, Skála J, ... Klinický obraz LSD psychozy po premedikaci 1-tyrosinem a dl-DOPA u chr... Activ. nerv. sup. 1968
Dallacker F Derivate des Methylendioxybenzols, 28. Mitt1: Über Reaktionen derDimet... Monatshefte fiir Che... 1969
Sankar DVS, Rozsa PW, Gei... Chromosome Breakage in Children Treated with LSD-25 and UML-491 Comprehens. Psychiat... 1969
Ludwig A, Levine J, Stark... A clinical study of LSD treatment in alcoholism (124th Annual Meeting ... Amer. J. Psychiat. 1969
Idänpään-Heikkilä JE, Sch... 14C-Lysergide in early pregnancy Lancet 1969
Skakkebaek WE, Philip J, ... Lysergidforarsagede aendringer i meiosekromosomer hos mus . Dansk Psy... Nord. Med. 1969
Vaccari A, Cugurra F, Ver... [3H](+)-amphetamine and [14C]-5-hydroxytryptamine: relationship betwee... 4th International co... 1969
Vick JA Cardiovascular effects of guanazole (NSC 1895) Proc. Amer. Ass. Can... 1969
Loew DM, Depoortere H, Vi... Wirkungen von D-Lysergsäurediäthylamid (LSd-25) und 2-Brom-D-Lysergsäu... Naunyn-Schmiedeberg'... 1970
Kmell J, Vizi ES, Knoll B Pharmacological studies on para-bromo-methamphetamine (V-111) and LSD Acta Physiol. Acad. ... 1970
Editorial Hauptreferate des FIP-Kongresses 1970 in Kurzfassung Schweiz. Apoth. -Ztg... 1970
Knoll J, Vizi ES Cross-tolerance between para-bromo-methamphetamine (V-111) and LSD-5 Pharmacology 1970
Knoll B, Vizi ES, Knoll J Pharmacology of p-bromo-methylamphetamine (V-111) Acta physiol. Acad. ... 1970
Vaccari A, Vertua R (14)C-5-Hydroxytryptamine and (3)H-D-Amphetamine: uptake and contracti... Biochem. Pharmacol. 1970
Shein HM, Wislon S, Larin... Stimulation of [14c] serotonin synthesis from [14c] tryptophan by mesc... Life Sci 1971
Franchi GC, Faniciullacci... Clinical pharmacology of the non-vasoconstrictor 1-methylated ergotami... Proceedings of the I... 1971
Hester JB, Rudzik AD, Kam... 6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines which have central n... J Med Chem 1971
Wu YH, Rayburn JW, Allen ... Psychosedative agents28-(4-Substituted 1-piperazinylalkyl)-8-azaspiro(... J Med Chem 1972
Depoortere H, Loew DM Alterations in the sleep/wakefulness cycle in rats after administratio... Brit. J. Pharmacol. 1972
Ronald T. Coutts and Jerr... The Synthesis of Analogs of the Hallucinogen 1-2,5-Dimethoxy-4-methylp... Can. J. Chem. 1973
Barfknecht CF, Nichols DE... Potential Psychotomimetics. 2-Amino-1,2,3,4-tetrahydronaphthalene Anal... J Med Chem 1973
Bye C, Munro-Faure AD, Pe... A comparison of the effects of 1-benzylpiperazine and dexamphetamine o... Eur J Clin Pharmacol 1973

Page 1 of 5   /   459 Entries Returned
Pages:     
 1 
2 3 4 5 next